Response of an ERBB2-Mutated Inflammatory Breast Carcinoma to Human Epidermal Growth Factor Receptor 2-Targeted Therapy

被引：41

作者：

Ali, Siraj M. ^{[1
]}

Alpaugh, R. Katherine ^{[2
]}

Downing, Sean R. ^{[1
]}

Stephens, Philip J. ^{[1
]}

Yu, Jian Q. ^{[2
]}

Wu, Hong ^{[2
]}

Buell, Jamie K. ^{[1
]}

Miller, Vincent A. ^{[1
]}

Lipson, Doron ^{[1
]}

Palmer, Gary A. ^{[1
]}

Ross, Jeffrey S. ^{[1
,3
]}

Cristofanilli, Massimo ^{[2
]}

机构：

[1] Fdn Med, Cambridge, MA 02141 USA

[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

[3] Albany Med Coll, Albany, NY 12208 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 25期

关键词：

KINASE MUTATIONS; CANCER;

D O I：

10.1200/JCO.2013.49.0599

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E88 / E91

页数：4

共 9 条

[1] Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer [J].

Bose, Ron ;

Kavuri, Shyam M. ;

Searleman, Adam C. ;

Shen, Wei ;

Shen, Dong ;

Koboldt, Daniel C. ;

Monsey, John ;

Goel, Nicholas ;

Aronson, Adam B. ;

Li, Shunqiang ;

Ma, Cynthia X. ;

Ding, Li ;

Mardis, Elaine R. ;

Ellis, Matthew J. .

CANCER DISCOVERY, 2013, 3 (02) :224-237

[2] International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment [J].

Dawood, S. ;

Merajver, S. D. ;

Viens, P. ;

Vermeulen, P. B. ;

Swain, S. M. ;

Buchholz, T. A. ;

Dirix, L. Y. ;

Levine, P. H. ;

Lucci, A. ;

Krishnamurthy, S. ;

Robertson, F. M. ;

Woodward, W. A. ;

Yang, W. T. ;

Ueno, N. T. ;

Cristofanilli, M. .

ANNALS OF ONCOLOGY, 2011, 22 (03) :515-523

[3] Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2 [J].

Greulich, Heidi ;

Kaplan, Bethany ;

Mertins, Philipp ;

Chen, Tzu-Hsiu ;

Tanaka, Kumiko E. ;

Yun, Cai-Hong ;

Zhang, Xiaohong ;

Lee, Se-Hoon ;

Cho, Jeonghee ;

Ambrogio, Lauren ;

Liao, Rachel ;

Imielinski, Marcin ;

Banerji, Shantanu ;

Berger, Alice H. ;

Lawrence, Michael S. ;

Zhang, Jinghui ;

Pho, Nam H. ;

Walker, Sarah R. ;

Winckler, Wendy ;

Getz, Gad ;

Frank, David ;

Hahn, William C. ;

Eck, Michael J. ;

Mani, D. R. ;

Jaffe, Jacob D. ;

Carr, Steven A. ;

Wong, Kwok-Kin ;

Meyerson, Matthew .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (36) :14476-14481

[4] Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer [J].

Piccart-Gebhart, MJ ;

Procter, M ;

Leyland-Jones, B ;

Goldhirsch, A ;

Untch, M ;

Smith, I ;

Gianni, L ;

Baselga, J ;

Bell, R ;

Jackisch, C ;

Cameron, D ;

Dowsett, M ;

Barrios, CH ;

Steger, G ;

Huang, CS ;

Andersson, M ;

Inbar, M ;

Lichinitser, M ;

Láng, I ;

Nitz, U ;

Iwata, H ;

Thomssen, C ;

Lohrisch, C ;

Suter, TM ;

Ruschoff, J ;

Süto, T ;

Greatorex, V ;

Ward, C ;

Straehle, C ;

McFadden, E ;

Dolci, MS ;

Gelber, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16) :1659-1672

[5] Inflammatory Breast Cancer The Disease, the Biology, the Treatment [J].

Robertson, Fredika M. ;

Bondy, Melissa ;

Yang, Wei ;

Yamauchi, Hideko ;

Wiggins, Shannon ;

Kamrudin, Samira ;

Krishnamurthy, Savitri ;

Le-Petross, Huong ;

Bidaut, Luc ;

Player, Audrey N. ;

Barsky, Sanford H. ;

Woodward, Wendy A. ;

Buchholz, Thomas ;

Lucci, Anthony ;

Ueno, Naoto ;

Cristofanilli, Massimo .

CA-A CANCER JOURNAL FOR CLINICIANS, 2010, 60 (06) :351-375

[6] The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine (Publication with Expression of Concern) [J].

Ross, Jeffrey S. ;

Slodkowska, Elzbieta A. ;

Symmans, W. Fraser ;

Pusztai, Lajos ;

Ravdin, Peter M. ;

Hortobagyi, Gabriel N. .

ONCOLOGIST, 2009, 14 (04) :320-368

[7] A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial Carcinomas [J].

Rudd, Meghan L. ;

Price, Jessica C. ;

Fogoros, Sarah ;

Godwin, Andrew K. ;

Sgroi, Dennis C. ;

Merino, Maria J. ;

Bell, Daphne W. .

CLINICAL CANCER RESEARCH, 2011, 17 (06) :1331-1340

[8] Intragenic ERBB2 kinase mutations in tumours [J].

Stephens, P ;

Hunter, C ;

Bignell, G ;

Edkins, S ;

Davies, H ;

Teague, J ;

Stevens, C ;

O'Meara, S ;

Smith, R ;

Parker, A ;

Barthorpe, A ;

Blow, M ;

Brackenbury, L ;

Butler, A ;

Clarke, O ;

Cole, J ;

Dicks, E ;

Dike, A ;

Drozd, A ;

Edwards, K ;

Forbes, S ;

Foster, R ;

Gray, K ;

Greenman, C ;

Halliday, K ;

Hills, K ;

Kosmidou, V ;

Lugg, R ;

Menzies, A ;

Perry, J ;

Petty, R ;

Raine, K ;

Ratford, L ;

Shepherd, R ;

Small, A ;

Stephens, Y ;

Tofts, C ;

Varian, J ;

West, S ;

Widaa, S ;

Yates, A ;

Brasseur, F ;

Cooper, CS ;

Flanagan, AM ;

Knowles, M ;

Leung, SY ;

Louis, DN ;

Looijenga, LHJ ;

Malkowicz, B ;

Pierotti, MA .

NATURE, 2004, 431 (7008) :525-526

[9] Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils [J].

Torti, Davide ;

Trusolino, Livio .

EMBO MOLECULAR MEDICINE, 2011, 3 (11) :623-636

← 1 →